TAVR pre-procedural checklist for clinical teams

TAVR Pre-Procedural Planning: Clinical Team Protocols

Each affects what happens in the catheterization lab, so the pre-procedural checklist for transcatheter aortic valve replacement is a clinical planning tool, not a formality. Its purpose is to bring the right specialists and information together before the procedure, identify unresolved risks, and make the team’s decisions visible in the record.

That work belongs to the whole structural heart team. A scan without a clear interpretation, a medication plan the patient has not understood, or a missing handoff can leave important decisions until the day of the procedure. The checklist works when it connects those decisions rather than simply collecting signatures.

Multidisciplinary Heart Team Coordination and ESC Standards

TAVR planning calls for multidisciplinary review. Interventional cardiologists, cardiac surgeons, imaging specialists, anesthesiologists, and the coordinator each contribute a different part of the assessment. The team considers the indication for intervention, the patient’s anatomy and comorbidities, the available treatment options, and the risks that could affect procedural planning.

ESC standards place the Heart Team at the center of this decision-making. They also include on-site cardiac surgical capability in the standard TAVR setting. This is not a detail to soften into a general preference: surgical backup is part of the guideline framework. The team’s review should document its clinical reasoning and agreed plan, including how the center is prepared to respond if a complication requires surgical intervention.

A useful division of work makes the review accountable without turning it into a paper exercise:

The coordinator’s role is practical: identify what is missing early enough for someone to act on it. A CT report that has not reached the operator, or a medication instruction that has not reached the patient, is not a completed task simply because it appears on a list.

The record should show the team’s conclusion, not just its attendance. That means recording the indication, the selected plan, relevant anatomic and clinical considerations, and any open issue that must be resolved before proceeding. These details make structural heart procedure documentation useful to the clinicians who inherit the case at each stage.

A clear record also preserves the reasoning behind decisions that may otherwise look arbitrary later. If the team selects one access route over another, or resolves a disagreement between imaging findings, the basis for that choice belongs in the plan. A useful handoff lets the next clinician understand not just what was decided, but what information shaped the decision.

Gold Standard Imaging: MDCT and Vascular Access Assessment

Echocardiography and CT answer different questions. Echocardiography is central to assessing valve hemodynamics and cardiac function. Multidetector CT (MDCT) provides the detailed anatomic assessment used for valve sizing and access planning. The measurements are complementary; echo should not be treated as a substitute for CT-based annular assessment when planning TAVR.

The annulus is not a simple circular opening. Its dimensions vary through the cardiac cycle, and its shape is often oval. CT allows the imaging team to assess the annulus in multiple planes and report measurements such as area and perimeter. Echo provides essential clinical information, but its imaging views and measurement approach differ. When the two methods do not appear to agree, the team should reconcile the findings rather than select a valve size from an isolated measurement.

The CT review should cover more than the annulus. The planning discussion commonly includes:

• Annular area and perimeter, with the sizing method and relevant measurements documented.
• Aortic root anatomy, including the sinuses of Valsalva and the relationship of the coronary ostia to the annulus.
• The distribution and extent of calcification on the valve leaflets, annulus, and adjacent structures.
• The caliber, tortuosity, and calcification of potential vascular access routes, beginning with the iliofemoral arteries and considering alternatives when needed.

Each result informs a different decision. Annular dimensions contribute to prosthesis selection. Root anatomy and coronary height help the team consider the risk of coronary obstruction. Calcification can affect valve expansion, sealing, and conduction. Access vessel size and disease help determine whether transfemoral delivery is suitable or whether another route merits consideration.

The CT report should make those findings usable at the planning conference. A list of measurements without interpretation leaves the operator to reconstruct the decision. A useful report states the measurements, describes relevant anatomy and limitations, and flags findings that could change valve choice or access strategy.

Echo establishes important hemodynamic context; CT supplies the detailed annular and vascular anatomy needed for TAVR planning.

The team should also check whether the imaging is adequate for the decision at hand. Motion, image quality, or incomplete coverage can limit interpretation, and that limitation belongs in the discussion. A measurement presented without its constraints can appear more certain than the scan allows.

The review is most useful when it ends with an actionable account of what the anatomy permits. That includes identifying whether the planned route is feasible, what alternatives are available if it is not, and which findings deserve particular attention during implantation. This is where imaging requirements for valve replacement become part of clinical planning rather than a list of tests to complete.

Functional Capacity Metrics and Baseline Quality of Life

An anatomic plan does not describe how the patient is functioning before intervention. Baseline measures give the team a clearer starting point for discussing expected benefit, anticipating support needs, and interpreting recovery afterward.

The 5-meter walk test offers a brief measure of gait speed and physical performance. It can help describe frailty and functional reserve, but it should be interpreted alongside the patient’s overall clinical picture. Pain, neurologic impairment, use of a walking aid, and other limitations may affect the result. The record should say how the test was performed and note circumstances that could make the time difficult to interpret.

The Kansas City Cardiomyopathy Questionnaire (KCCQ-12) captures the patient’s account of symptoms and health-related quality of life. It does not replace clinical assessment. Its value lies in making the patient’s baseline experience visible in a structured form, so that later assessment can be compared with a documented starting point.

When feasible, collecting the same measures at follow-up can help the team assess changes in function and reported health status. Those changes should be considered with the broader clinical course, not treated as standalone proof that a procedure succeeded or failed.

For clinical assessment before TAVR, the point is to connect the scores with a real conversation. A low walking-test performance may prompt questions about mobility and recovery support. A poor quality-of-life score may sharpen discussion of symptom burden and the goals of treatment. A reassuring score does not erase severe valve disease or other risks. Metrics are most useful when they add detail to the Heart Team’s judgment rather than stand in for it.

That conversation can also uncover barriers that a score alone cannot explain. A patient may be limited by joint pain or lung disease as well as valve symptoms; someone else may be independent at home but lack support for the first stage of recovery. Recording the patient’s own account helps the team interpret the measures and make discharge and follow-up planning more realistic.

Infection Prophylaxis and Dental Clearance

Oral health belongs in pre-procedure planning because untreated dental infection may require attention before an implanted valve is placed. Patients with natural teeth require dental clearance before TAVR. The assessment identifies active infection and other pathology, and treatment is tailored to the findings rather than applied as a blanket intervention.

For patients with natural teeth, the team should arrange dental assessment early enough for the clinician to evaluate oral health and manage any condition that requires treatment before the procedure. The dental findings, treatment provided or planned, and clearance should be documented. For edentulous patients, an oral examination may still be appropriate when the clinical history or examination raises concern; the absence of natural teeth alone does not answer every question about oral infection.

A workable process keeps responsibilities clear:

1. At the valve clinic visit, establish the patient’s dental status and arrange dental clearance for patients with natural teeth.

2. Allow time for the dental clinician to assess the patient and treat active disease or other relevant pathology.

3. Record the findings, treatment plan, clearance, and any follow-up required before the procedure.

Dental assessment and antibiotic prophylaxis are separate decisions. Prophylaxis should follow applicable guidance and the patient’s clinical circumstances, not an assumption that every dental visit or every TAVR patient requires the same regimen. Clear documentation helps prevent both missed infection and unnecessary, last-minute medication decisions.

If dental treatment is required, its timing should be coordinated with the structural heart team. The record should make clear what has been completed and whether anything remains that could affect the planned procedure. This gives the team a basis for deciding whether it can proceed as scheduled or needs to resolve an outstanding clinical concern first.

Anticoagulation Management and Pre-Op Fasting Protocols

Medication planning should start before the day of TAVR. The team needs a current list that includes prescription medicines, over-the-counter drugs, and the reason for each antithrombotic. The plan then has to be specific enough for the patient to follow and for the procedural team to verify.

Antiplatelet and anticoagulant decisions depend on the indication for treatment, renal function, bleeding risk, thrombotic risk, and the local procedural plan. A generic instruction to stop blood thinners is inadequate: interruption may create thrombotic risk, while continuation may affect bleeding management. The responsible clinician should document which medicines to take or hold, when the plan begins, and when treatment is expected to resume. If a medication plan changes, the change should reach the patient and the procedure team.

The same caution applies to specific drugs and timing. Direct oral anticoagulants, warfarin, heparin, and low-molecular-weight heparin have different considerations. A single interval or INR target cannot safely replace a plan tailored to the agent and patient. Bridging decisions, where relevant, also require individualized assessment rather than automatic application.

Written instructions reduce the chance that patient and team are working from different versions of the plan. Before the procedure, someone should confirm what the patient actually took and when. That check can expose misunderstandings while there is still time to respond. It should include a route for resolving uncertainty, particularly if the patient has followed an older instruction or is unsure whether a dose was taken.

Fasting instructions should follow the institution’s anesthesia protocol and account for the planned anesthetic, aspiration risk, diabetes, and other relevant conditions. The patient needs clear directions on food, clear fluids, and routine medicines, including what to do if the schedule changes. The anesthesia team should verify the instructions and any departures from them before the procedure begins.

A pre-op instruction is useful only if it reaches the patient in a form they can act on. The team should confirm that the patient understands which medicines are affected, when fasting begins, and whom to contact if the procedure time or health status changes. That confirmation is part of preparation, not an administrative afterthought.

Closing the Loop Before the Procedure

The final review is a handoff, not a recitation. The team should be able to find the imaging and Heart Team decision, understand the access and implantation plan, and see that medication, anesthesia, and infection-related questions have been addressed. The patient should know what to expect and whom to contact if instructions are unclear.

A concise procedure-day review can cover the essentials without pretending every patient follows an identical pathway:

• Relevant imaging is available, reviewed, and adequate for the planned decisions.
• The Heart Team’s recommendation and procedural plan are documented.
• Access planning and any unresolved anatomic concern have been addressed.
• Medication instructions have been reconciled with what the patient took.
• Dental findings and clearance are recorded for patients with natural teeth, with follow-up needs noted.
• Baseline functional and quality-of-life assessments are available when obtained.
• Anesthesia planning, fasting instructions, consent, and required laboratory results have been reviewed.

A missing item should trigger a decision: obtain it, document why it is not required, or pause to resolve its clinical importance. That is the difference between a checklist as paperwork and a checklist as a safety tool.

TAVR preparation is strongest when the team treats each result as part of a connected plan. CT informs sizing and access; the Heart Team interprets those findings in light of the patient’s goals and risks; medication and anesthesia plans turn the decision into a procedure that the patient can safely reach. The checklist cannot guarantee an uncomplicated case. It can make assumptions visible before they become problems in the catheterization lab.